Module

Changes in Staging Classification for Breast Cancer 2005

Source: Breast Cancer Annual Update 2005

Changes in Staging Classification for Breast Cancer 2005


Program Director: Clifford A. Hudis, MD

Faculty:

  • S. Eva Singletary, MD, FACS

CME CREDIT INFORMATION

Release Date: 10/11/05

Expiration Date: 10/10/06


Physicians: maximum of 1 AMA PRA Category 1 Credit(s)™

Registered Nurses: 1.2 Nursing CE credits

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe recent changes in the staging of breast cancer, based on updates to the American Joint Committee on Cancer Staging Manual.

  • Explain the rationale for these changes in staging, based on current scientific literature.

  • Identify areas of potential change for the future, based on technologic advances and ongoing clinical research.


Content includes:

  • Descriptors in the TNM Staging System
  • Impact of ITCs and Micrometastases on Outcome
  • Impact of Location of Lymph Node Metastases
  • Impact of Location of Lymph Node Metastases
  • Prognostic Significance of Tumor Grade
  • Future of Staging—Gene Profiling
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.